Posts Tagged ‘hep c’

Previously Unforeseen Risk Tarnishes Hep C Wonder Drugs

The improvement in Hepatitis C treatment success marks a dramatic change in the prognosis for most Hepatitis C diagnoses. New direct-acting antiviral drugs boast viral eradication rates in the high 90th percentile, rendering hope that the Hepatitis C virus can be eradicated. Until recently, the only major obstacle surrounding these Hepatitis C medications has been…

Read More

Hepatitis C Disease – Progression and Management

Hepatitis C Disease – Progression and Management After exposure to the hepatitis C virus, the window period before antibodies can be detected using a standard test usually lasts from 2 to 26 weeks. The initial phase of hepatitis C is called acute infection. Acute HCV infection may resolve with spontaneous viral clearance, typically within 2–12 weeks.…

Read More

What Is Hepatitis C Viral Load?

If you’re being treated for hepatitis C virus infection — also called HCV– your doctor is keeping track of your viral load. What is HCV viral load? Why does it matter? WebMD got answers to your most frequently asked questions about hepatitis C and viral load from two experts: Frank Anania, MD, associate professor of…

Read More

Treating Hep C: Effective but Expensive

Last month, the Food and Drug Administration (FDA) approved another in a series of medicines that have dramatically changed the outlook for those diagnosed with hepatitis C. Epclusa is a single pill taken once a day for 12 weeks. It is the first drug to clear all six strains of the virus in up to…

Read More

Another study confirms detrimental effects of delaying hepatitis C treatment

Another study confirms detrimental effects of delaying hepatitis C treatment Liz Highleyman Produced in collaboration with hivandhepatitis.com Published: 05 May 2015 Deferring antiviral therapy for hepatitis C until a person progresses to advanced liver disease has clear drawbacks including lower treatment effectiveness and an increased risk of clinical events and death, according to a study…

Read More